Chronic kidney disease
Chronic kidney disease (CKD) is a persistent disorder of kidney structure or function, typically assessed using estimated glomerular filtration rate (eGFR) and albuminuria or proteinuria.
Chronic kidney disease (CKD) is a persistent disorder of kidney structure or function, typically assessed using estimated glomerular filtration rate (eGFR) and albuminuria or proteinuria. Progressive nephron injury can reduce glomerular filtration and promote renal fibrosis, ultimately leading to kidney failure and, in advanced cases, dialysis or end-stage renal failure. CKD is closely associated with type 2 diabetes, hypertension, obesity, cardiovascular disease, heart failure, anaemia, and abnormal lipid metabolism; its clinical burden varies across KDIGO-defined eGFR and albuminuria categories.
Current research emphasizes individualized prediction of CKD development and progression using combined clinical, metabolic, inflammatory, nutritional, and exposure-related data. Recent studies have examined prediction after radical nephrectomy, immune-inflammatory markers in older adults with obesity, atherogenicity in people with diabetes, and kidney injury after ifosfamide chemotherapy in children. Sodium glucose cotransporter-2 (SGLT2) inhibitors are an important treatment-related focus in populations with diabetes, CKD, or heart failure, although prescribing gaps remain. Other investigations are characterizing podocyte damage and testing antifibrotic mechanisms, including S1PR2 and the RhoA/ROCK pathway, to better define disease trajectories and potential therapeutic targets.
Where the papers sit
12 papers from the last 6 months study chronic kidney disease directly · updated from PubMed 14 Nov 2026
Study type 0 clinical trials · 4 observational · 5 human data · 1 preclinical · 2 unclassified
Themes one subject · 1 new direction
Those 12 are all about one subject.
-
CKD Risk Assessment and Epidemiology
Risk stratification is moving toward explainable machine learning, deep learning from echocardiography, and multicenter validation after nephrectomy. Hemoglobin, albumin, lymphocyte and platelet measures, inflammatory indices, atherogenicity, nutrition, anaemia and body composition recur as accessible risk markers. Population analyses define changing CKD prevalence across eGFR, albuminuria, diabetes and comorbidity groups, while single-cell studies track organ-specific damage. The clinical gap remains implementation, including underuse of SGLT2 inhibitors and surveillance of childhood cancer survivors.
CKD becomes a cell-resolved damage trajectory rather than only a clinical outcome or risk state
The chronic kidney disease and metabolic dysfunction-associated steatotic liver disease study treats CKD as a system for mapping continuous, cell-intrinsic degeneration, rather than as an aggregate diagnosis, prognostic endpoint, comorbidity, or treatment-eligibility category. Using single-cell and spatial transcriptomics alongside proteomics, histology, and clinical data, it places individual podocytes on a health-to-damage axis, links podocyte injury to focal segmental glomerulosclerosis progression and circadian disruption, and aligns disease models with unperturbed cells. This changes the role of CKD from a condition to be detected or predicted into a cellular trajectory that can be quantitatively resolved across disease stages 42624116Aug.
Papers
The 12 papers from the last 6 months that study chronic kidney disease directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
CKD Risk Assessment and Epidemiology (12)
- An explainable machine learning framework for cross-dataset chronic kidney disease risk prediction using hybrid data balancing. PloS one · 5 Nov 2026 PMID 42986869
- Association between the hemoglobin albumin lymphocyte and platelet score and chronic kidney disease: Insights from patient data and animal models. PloS one · 14 Oct 2026 PMID 42873799
- Identification and validation of a chronic kidney disease prediction model after radical nephrectomy: a multicenter cohort retrospective study. Annals of medicine · 29 Sept 2026 PMID 42808223
- Association of immune-inflammatory markers with chronic kidney disease in older adults with obesity: a large-scale cross-sectional study. Renal failure · 24 Sept 2026 PMID 42785974
- Deep learning-enabled screening of chronic kidney disease from echocardiography. Med (New York, N.Y.) · 18 Sept 2026 PMID 42759502
- Comprehensive trends in Chronic Kidney Disease prevalence and comorbidities across eGFR and albuminuria categories: a 20-year analysis of NHANES data. Renal failure · 15 Sept 2026 PMID 42736589
- The SGLT2i Treatment Gap in UK Primary Care: A Cross-Sectional RWE Study of Prescribing in Clinical Practice. Diabetes, obesity & metabolism · 11 Sept 2026 PMID 42723263
- Trends in type 1 and type 2 diabetic kidney disease in China, the USA, and the UK, 1990-2023. Diabetes research and clinical practice · 3 Sept 2026 PMID 42692262
- Chronic Kidney Disease in Children Within Five Years After Ifosfamide Chemotherapy for Childhood Cancer: A Dutch Pediatric Oncology Cohort Study. Cancer medicine · 31 Aug 2026 PMID 42670233
- Multidimensional nutritional and body-composition phenotypes and their associations with prevalent anaemia and metabolic abnormalities in CKD: protocol for an EHR-based retrospective baseline cross-sectional study with a prospective measurement extension. BMJ open · 24 Aug 2026 PMID 42637263
- Cell-type-specific damage scores reveal kidney and liver disease trajectories in single-cell and spatial transcriptomics. Cell genomics · 20 Aug 2026 PMID 42624116
- The association between atherogenic index of plasma, cumulative atherogenic index of plasma and type 2 diabetes mellitus with chronic kidney disease among older Chinese adults: Findings from the CHARLS study. PloS one · 7 Aug 2026 PMID 42566486
By study type
Observational studies and case reports (4)
- Identification and validation of a chronic kidney disease prediction model after radical nephrectomy: a multicenter cohort retrospective study. Annals of medicine · 29 Sept 2026 PMID 42808223
- Association of immune-inflammatory markers with chronic kidney disease in older adults with obesity: a large-scale cross-sectional study. Renal failure · 24 Sept 2026 PMID 42785974
- Chronic Kidney Disease in Children Within Five Years After Ifosfamide Chemotherapy for Childhood Cancer: A Dutch Pediatric Oncology Cohort Study. Cancer medicine · 31 Aug 2026 PMID 42670233
- Multidimensional nutritional and body-composition phenotypes and their associations with prevalent anaemia and metabolic abnormalities in CKD: protocol for an EHR-based retrospective baseline cross-sectional study with a prospective measurement extension. BMJ open · 24 Aug 2026 PMID 42637263
Human data, design not indexed (5)
- An explainable machine learning framework for cross-dataset chronic kidney disease risk prediction using hybrid data balancing. PloS one · 5 Nov 2026 PMID 42986869
- Deep learning-enabled screening of chronic kidney disease from echocardiography. Med (New York, N.Y.) · 18 Sept 2026 PMID 42759502
- Comprehensive trends in Chronic Kidney Disease prevalence and comorbidities across eGFR and albuminuria categories: a 20-year analysis of NHANES data. Renal failure · 15 Sept 2026 PMID 42736589
- Trends in type 1 and type 2 diabetic kidney disease in China, the USA, and the UK, 1990-2023. Diabetes research and clinical practice · 3 Sept 2026 PMID 42692262
- The association between atherogenic index of plasma, cumulative atherogenic index of plasma and type 2 diabetes mellitus with chronic kidney disease among older Chinese adults: Findings from the CHARLS study. PloS one · 7 Aug 2026 PMID 42566486
Preclinical: animal, cell and lab studies (1)
- Association between the hemoglobin albumin lymphocyte and platelet score and chronic kidney disease: Insights from patient data and animal models. PloS one · 14 Oct 2026 PMID 42873799
Unclassified: not yet indexed with MeSH (2)
- The SGLT2i Treatment Gap in UK Primary Care: A Cross-Sectional RWE Study of Prescribing in Clinical Practice. Diabetes, obesity & metabolism · 11 Sept 2026 PMID 42723263
- Cell-type-specific damage scores reveal kidney and liver disease trajectories in single-cell and spatial transcriptomics. Cell genomics · 20 Aug 2026 PMID 42624116
Written from 12 PubMed abstracts, each one listed by PMID above. Published: 2026-10-01. Drafted by language models from published abstracts; not medical advice.